Lumos Diagnostics Holdings Limited (LDX.AX)

0.0570 -0.0010 (-1.72%) At close: 04:10PM AEST

Lumos Diagnostics Holdings Limited

100 Albert Road
Level 4 South Melbourne
Melbourne, VIC 3205
Australia
61 3 9087 1598
https://lumosdiagnostics.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Samuel Lanyon	Executive Chairman	171.24k	N/A	N/A
Mr. Douglas Ward	CEO, MD & Director	934.52k	N/A	N/A
Mr. Barrie Lambert	Chief Financial Officer	571.12k	N/A	N/A
Dr. Sacha Dopheide Ph.D.	Chief Technology Officer	N/A	N/A	N/A
Ms. Jennifer Christiansen	Vice President of Corporate Marketing & Communications	N/A	N/A	N/A
Ms. Sarah Glubka	Senior Director of Human Resources	N/A	N/A	N/A
Mr. Paul Kase	Senior Vice President of Commercial Operations	N/A	N/A	N/A
Ms. Tracy Weimar BA, MBA	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Lumos Diagnostics Holdings Limited, a contract research and development company, develops, manufactures, and commercializes rapid point-of-care (POC) diagnostic products for diagnosis and management of infectious diseases in the United States and Australia. The company's products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.

Corporate governance

Lumos Diagnostics Holdings Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.